Polypharmacy is therefore common in people with CKD 2, rendering them vulnerable to medication-related problems, 5 including adverse drug events and/or CKD
by RL Castelino 2024 Cited by 35Chronic kidney disease (CKD) affects drug elimination and patients with CKD require appropriate adjustment of renally cleared medications to
CKD. S205. Chapter 3: Delaying CKD progression and managing its complications. S246. Chapter 4: Medication management and drug stewardship in CKD. S255. Chapter
What is gabapentin? Type of drug: gamma aminobutyric acid (GABA) analogue Use: itching in CKD; chronic pain; epilepsy Dose: in CKD, start low
What is gabapentin? Type of drug: gamma aminobutyric acid (GABA) analogue Use: itching in CKD; chronic pain; epilepsy Dose: in CKD, start low
What is gabapentin? Type of drug: gamma aminobutyric acid (GABA) analogue; Use: itching in CKD; chronic pain; epilepsy; Dose: in CKD
by A Ortiz 2024treat hyperkalemia, especially in CKD, which is characterized SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also.
by PE Stevens 2024 Cited by 95Medication management and drug stewardship in CKD. S255, Chapter 5: Optimal CKD, complications of CKD, and adverse events? Figure S7. PRISMA diagram
pain for patients with renal dysfunction. Dosing considerations in chronic. kidney disease (CKD). CKD alters renal drug elimination by affecting
Comments
LWlurker